N-[2-(3,4-DIMETHYLPHENOXY)ETHYL]-N-METHYLAMINE
- $45 - $776.16
- Product name: N-[2-(3,4-DIMETHYLPHENOXY)ETHYL]-N-METHYLAMINE
- CAS: 883529-57-5
- MF: C11H17NO
- MW: 179.26
- EINECS:
- MDL Number:MFCD06247221
- Synonyms:[2-(3,4-DIMETHYL-PHENOXY)-ETHYL]-METHYL-AMINE;AKOS BC-1947;N-[2-(3,4-DIMETHYLPHENOXY)ETHYL]-N-METHYLAMINE;2-(3,4-dimethylphenoxy)-N-methylethanamine;Ethanamine, 2-(3,4-dimethylphenoxy)-N-methyl-;2-(3,4-Dimethylphenoxy)-N-methylethan-1-amine
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
- TRC
Package
- 5mg
- 500mg
- ManufacturerAK Scientific
- Product number1638AF
- Product descriptionN-[2-(3,4-Dimethylphenoxy)ethyl]-N-methylamine
- Packaging500mg
- Price$294
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0033831
- Product descriptionN-[2-(3,4-DIMETHYLPHENOXY)ETHYL]-N-METHYLAMINE 95.00%
- Packaging500MG
- Price$776.16
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number013743
- Product descriptionN-[2-(3,4-Dimethylphenoxy)ethyl]-N-methylamine
- Packaging500mg
- Price$181
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD688338
- Product descriptionN-[2-(3,4-Dimethylphenoxy)ethyl]-N-methylamine
- Packaging5mg
- Price$45
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 1638AF | N-[2-(3,4-Dimethylphenoxy)ethyl]-N-methylamine | 500mg | $294 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0033831 | N-[2-(3,4-DIMETHYLPHENOXY)ETHYL]-N-METHYLAMINE 95.00% | 500MG | $776.16 | 2021-12-16 | Buy |
Matrix Scientific | 013743 | N-[2-(3,4-Dimethylphenoxy)ethyl]-N-methylamine | 500mg | $181 | 2021-12-16 | Buy |
TRC | D688338 | N-[2-(3,4-Dimethylphenoxy)ethyl]-N-methylamine | 5mg | $45 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|